Article
Reprogramming of serine metabolism is an actionable vulnerability in <i>FLT3</i> - <i>ITD</i> driven acute myeloid leukaemia
2020-05-27
Abstract excerpt
Activating FMS-like tyrosine kinase 3 ( FLT3 ) mutations occur in approximately 30% of all acute myeloid leukaemias (AMLs) and are associated with poor prognosis. The limited clinical efficacy of FLT3 inhibitor monotherapy has highlighted the need for alternative therapeutic targets and treatments for FLT3-mutant AML. Using human and murine models of MLL-rearranged AML harbouring FLT3 internal tandem duplication...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cd93d70d-9b34-56c7-aa8c-013398951d78
- DOI
- 10.1101/2020.05.26.116392
